ANCA-associated vasculitis: open trials in Sweden

• NCT06047171

  Rescue of Nephrons With ALE.F02 (RENAL-F02)

  Trial Treatment · Phase 2 · Alentis Therapeutics AG

  Linkoping University Hospital, Linköping · University Hospital of Umeå, Umeå

  Registry updated 2026-08-14

• 2023-508398-10-00

  Discontinuation of rituximab compared with rituximab maintenance in ANCA-associated vasculitis – a randomized non-blinded controlled trial (DISRITUX)

  Trial Treatment · Phase 4 · Region Oestergoetland

  Danderyds Sjukhus AB, Danderyd · Region Dalarna, Falun · Sahlgrenska University Hospital-Vaestra Goetalandsregionen, Goteborg · Karolinska University Hospital, Huddinge · Region Joenkoepings Laen, Jonkoping · Region Vaermland, Karlstad · Region Oestergoetland, Linkoping · Region Skane Skanes Universitetssjukhus, Lund · Region Oerebro Laen, Orebro · Karolinska University Hospital, Solna · Region Vaesterbotten, Umea · Uppsala University Hospital, Uppsala

  Registry updated 2026-07-08

• NCT06308978

  A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

  Trial Treatment · Phase 1 · Fate Therapeutics

  Uppsala University, Uppsala

  Registry updated 2026-05-22

All ANCA-associated vasculitis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error